Subject No. | Gender | Age | Hepatitis C Genotype | Duration of Therapy (weeks) | SVR | End of Rx TSH | TSH at 12 months | TSH at 24 months | TSH at 36 months |
---|---|---|---|---|---|---|---|---|---|
1 | M | 26 | 1a | 48 | Y | 2.1 | 1.8 | 2.8 | 3.4 |
2 | M | 51 | 2 | 24 | Y | 1.7 | 3.2 | 3.1 | 2.7 |
3 | M | 54 | 3 | 24 | Y | 3.8 | 2.3 | 2.2 | 3.2 |
4 | M | 49 | 4 | 48 | Y | 1.1 | 1.4 | 2.1 | 2.3 |
5* | F | 42 | 2 | 24 | Y | 1.6 | 1.8 | 2.1 | 1.9 |
6* | F | 34 | 3 | 24 | Y | 2.4 | 2.7 | 2.1 | 2.0 |
7 | F | 49 | 4 | 48 | Y | 3.1 | 2.9 | 2.7 | 2.2 |
8* | F | 49 | 1 | 48 | Y | 0.03 | 1.5 | 1.2 | 1.3 |
9 | F | 50 | 2 | 24 | Y | 2.2 | 2.1 | 2.4 | 2.5 |
10* | F | 37 | 4 | 48 | Y | 6.5 | 4.5 | 5.2 | 2.3 |
11 | F | 43 | 4 | 48 | Y | 1.8 | 1.9 | 2.3 | 2.1 |
12 | F | 42 | 3 | 24 | Y | 2.1 | 2.3 | 1.7 | 2.5 |
13* | F | 43 | 1 | 48 | N | 10.5 | 2.3 | 1.8 | 2.4 |
14* | F | 51 | 3 | 24 | Y | 8.8 | 4.0 | 3.8 | 2.3 |
15 | M | 57 | 1 | 48 | N | 2.2 | 2.7 | 1.9 | 1.2 |
16 | F | 38 | 3 | 24 | Y | 1.9 | 2.2 | 2.3 | 3.7 |
17 | M | 57 | 1 | 48 | Y | 4.5 | 2.5 | 3.6 | 2.8 |
18 | F | 37 | 3 | 24 | Y | 3.4 | 3.3 | 2.5 | 2.8 |